Analytical Data
-
基因名
SLC25A16
- Application
-
别名
SLC25A16; GDA; Graves disease carrier protein; GDC; Graves disease autoantigen; Mitochondrial solute carrier protein homolog; Solute carrier family 25 member 16
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P16260
-
表达区间
1-332 aa
-
氨基酸序列
MAAATAAAALAAADPPPAMPQAAGAGGPTTRRDFYWLRSFLAGGIAGCCAKTTVAPLDRVKVLLQAHNHHYKHLGVFSALRAVPQKEGFLGLYKGNGAMMIRIFPYGAIQFMAFEHYKTLITTKLGISGHVHRLMAGSMAGMTAVICTYPLDMVRVRLAFQVKGEHSYTGIIHAFKTIYAKEGGFFGFYRGLMPTILGMAPYAGVSFFTFGTLKSVGLSHAPTLLGRPSSDNPNVLVLKTHVNLLCGGVAGAIAQTISYPFDVTRRRMQLGTVLPEFEKCLTMRDTMKYVYGHHGIRKGLYRGLSLNYIRCIPSQAVAFTTYELMKQFFHLN
-
分子量
62.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC25A16, a member of the solute carrier family 25, encodes a mitochondrial transporter involved in the exchange of metabolites across the inner mitochondrial membrane. Recent studies have highlighted its critical role in cellular metabolism, particularly in the transport of acylcarnitines and amino acids essential for fatty acid oxidation and energy production. Dysregulation or mutations within SLC25A16 have been associated with metabolic disorders, including mitochondrial diseases, that can lead to compromised energy homeostasis and various health complications. The recombinant expression and characterization of SLC25A16 protein have garnered significant interest within the scientific community, as these studies facilitate a better understanding of its function and mechanisms. By producing purified SLC25A16 in suitable expression systems, researchers aim to investigate its transport properties, substrate specificity, and functional interactions with other mitochondrial proteins. This research not only contributes to foundational knowledge of mitochondrial transport processes but also has implications for potential therapeutic targets in metabolic diseases. Moreover, understanding the functional dynamics of SLC25A16 can provide insights into the development of interventions aimed at restoring normal mitochondrial function and improving metabolic health. Overall, the study of SLC25A16 recombinant protein is a vital step towards unraveling the complexities of mitochondrial transport mechanisms and their impact on human health.
